In our recent study, we demonstrated that DEX or TGF-β2 resulted in mildly and severely downsized and stiff 3D HTM spheroids, respectively, thus making them viable in vitro HTM models for steroid-induced (SG) and primary open-angle glaucoma (POAG). The gene discussed is TGFB2; the disease is open-angle glaucoma.